Skip to Main Content

Paper Details

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis.
Leukemia
17
2019
essential thrombocythemia, patients, pegylated interferon alfa-2a, polycythemia vera, splanchnic vein thrombosis
Author NameAffiliation
Judith D GoldbergNew York University School of Medicine
Judith D GoldbergNew York University School of Medicine
  • 1 - 2

Datasets

Release 1.2